FBIO
Fortress Biotech Inc
2.30$
+0.0%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -42.6% | -34.7% | +14.3% | -1.8% | +3.4% | -13.1% | +24.9% | +7.4% | -8.8% | -0.3% | +16.7% | – | |
| – | -6.4% | -0.2% | +9.0% | -19.2% | +9.8% | -17.5% | +3.1% | +16.5% | -5.5% | +35.0% | -3.2% | – | |
| – | -50.8% | -49.6% | +18.9% | +11.8% | -0.3% | -10.4% | +37.4% | +3.5% | -10.4% | -18.3% | +33.5% | – | |
| – | -30.8% | +76.5% | -49.0% | -25.5% | +5.2% | -60.4% | +106.3% | -97.4% | +76.4% | +47.1% | +49.1% | – | |
| – | +4.0% | -20.7% | +16.1% | +5.6% | +22.1% | -4.5% | +51.0% | -55.1% | -15.4% | +7.9% | +30.9% | – | |
| – | -20.3% | +30.0% | -17.1% | -13.0% | +16.6% | -16.4% | +56.4% | -61.0% | -17.4% | +6.5% | +31.5% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -18.7% | +26.3% | -18.4% | +192.6% | -58.2% | -3.2% | -17.4% | +16.4% | -29.2% | +97.1% | -56.2% | – | |
| – | – | – | – | – | – | – | – | – | -170.2% | – | -99.4% | – | |
| – | +168.8% | -553.6% | – | – | +387.0% | – | – | – | -3,238.5% | – | -94.2% | – | |
| – | – | – | – | – | – | – | – | -62.2% | -167.3% | – | -100.4% | – | |
| – | – | – | – | – | – | – | – | – | -126.9% | – | -97.7% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.